Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

Theraclion SA
PAR:ALTHE

Watchlist Manager
Theraclion SA Logo
Theraclion SA
PAR:ALTHE
Watchlist
Price: 0.666 EUR 2.46% Market Closed
Market Cap: €31.3m
Write Note Create Alert Ask AI

Theraclion SA
Investor Relations

Théraclion SA develops, manufactures, and markets oncological medical equipment. The company is headquartered in Malakoff, Ile-De-France. The company went IPO on 2014-04-25. The firm is a a spin-off of Inserm and EDAPTechomed. The main activity of the Company is developping, manufacturing and marketing echotherapy medical equipments associating therapy by focused ultrasound and monitoring by ultrasound. The firm provides Echopulse, a device for the non-invasive and outpatient treatment of the fibroadenoma of the breast and thyroid nodules.

Show more
Loading
ALTHE
DAX Index
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Yann M. Duchesne
Executive Chairman
No Bio Available
Mr. Martin Deterre
Chief Executive Officer
No Bio Available
Mr. Christophe Lamboeuf
Chief Financial Officer
No Bio Available
Gaylord Tallec
Vice President of Operations
No Bio Available
Jérémie Anquez
VP Research & Chief Scientific Officer
No Bio Available
Mr. Jose Abellan-Martinez
Vice President of Sales & Business Development
No Bio Available
Marie Berne
Marketing & Customer Relations Director
No Bio Available
Mr. Michel Nuta M.D.
VP of Veins & Chief Medical Officer
No Bio Available

Contacts

Address
ILE-DE-FRANCE
Malakoff
102, rue Etienne Dolet
Contacts
+33155489070.0
www.theraclion.fr
sparklesyt

See Also

Summary
ALTHE intrinsic value, competitors valuation, and company profile.
DCF Valuation
ALTHE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ALTHE stock valuation using valuation multiples.
Wall Street Estimates
ALTHE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ALTHE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 314,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.